
BioInfra Life Science Inc.
Biotech specializing in oncology diagnostics and R&D for cancer gene treatments.
266470 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 금천구 가산로9길 66 제1동 712호(가산동, 더리즌밸리지식산업센터), 서울특별시
- Website:
- http://bioinfra.co.kr/?lang=en
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BioInfra Life Science Inc. is a global healthcare and biotechnology company specializing in oncology. The company focuses on cancer prevention and early detection through its proprietary Multi-Biomarker Blood Test, a technology developed over more than 15 years of research that analyzes a small blood sample to assess the risk for eight major cancers. In addition to diagnostics based on protein chip technology, BioInfra is engaged in the research and development of cancer gene treatments, localized drug delivery systems, and technologies to monitor metastasis and recurrence. Established in 2001, the company aims to improve cancer survival rates through innovative healthcare solutions.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BioInfra Life Science Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
No filings match the current criteria. |
Automate Your Workflow. Get a real-time feed of all BioInfra Life Science Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BioInfra Life Science Inc. via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |